Filing Details

Accession Number:
0000950170-23-048195
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-09-14 16:30:13
Reporting Period:
2023-09-13
Accepted Time:
2023-09-14 16:30:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1840904 Atai Life Sciences N.v. ATAI Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1860682 Florian Brand Wallstrabe 16
Berlin 2M 10179
See Remarks No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Acquisiton 2023-09-13 40,000 $1.45 110,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Shares 2,333 Indirect By Spouse
Footnotes
  1. The price reported is a weighted average price. The securities were purchased in multiple transactions at per share prices ranging from $1.441 to $1.457. The Reporting Person undertakes to provide upon request the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote.